- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Patent holdings for IPC class C12Q 1/6886
Total number of patents in this class: 11894
10-year publication summary
|
296
|
410
|
813
|
1152
|
1236
|
1184
|
1269
|
1348
|
1303
|
795
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1156 |
299 |
| The Regents of the University of California | 20015 |
182 |
| Dana-Farber Cancer Institute, Inc. | 2574 |
173 |
| The Johns Hopkins University | 5689 |
165 |
| Guardant Health, Inc. | 430 |
154 |
| Mayo Foundation for Medical Education and Research | 3230 |
138 |
| The General Hospital Corporation | 4751 |
135 |
| Foundation Medicine, Inc. | 365 |
133 |
| The Board of Trustees of the Leland Stanford Junior University | 6441 |
116 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
113 |
| Memorial Sloan-Kettering Cancer Center | 1937 |
112 |
| Board of Regents, The University of Texas System | 5828 |
102 |
| Exact Sciences Corporation | 299 |
93 |
| The Broad Institute, Inc. | 1831 |
89 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2867 |
89 |
| National Cancer Center | 420 |
85 |
| Grail, Inc. | 220 |
81 |
| Genentech, Inc. | 3979 |
79 |
| Centre National de La Recherche Scientifique | 10476 |
75 |
| Toray Industries, Inc. | 6966 |
70 |
| Other owners | 9411 |